Anna Vanazzi

ORCID

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 7

Top Venues

Blood advances

This page only lists publications with an associated author ORCID identifier.

Publications

Annarita Conconi, Annalisa Chiappella, Andrés José Maria Ferreri, Anastasios Stathis, Barbara Botto, Marianna Sassone, Gianluca Gaidano, Monica Balzarotti, Francesco Merli, Alessandra Tucci, Anna Vanazzi, Monica Tani, Riccardo Bruna, Lorella Orsucci, Maria Giuseppina Cabras, Melania Celli, Ombretta Annibali, Anna Marina Liberati, Manuela Zanni, Chiara Ghiggi, Francesco Pisani, Graziella Pinotti, Fausto Dore, Fabiana Esposito, Maria Cristina Pirosa, Marina Cesaretti, Luisella Bonomini, Umberto Vitolo, Emanuele Zucca
IELSG30 phase 2 trial: intravenous and intrathecal CNS prophylaxis in primary testicular diffuse large B-cell lymphoma. Blood advances (2024)
Annarita Conconi, Annalisa Chiappella, Andrés José Maria Ferreri, Anastasios Stathis, Barbara Botto, Marianna Sassone, Gianluca Gaidano, Monica Balzarotti, Francesco Merli, Alessandra Tucci, Anna Vanazzi, Monica Tani, Riccardo Bruna, Lorella Orsucci, Maria Giuseppina Cabras, Melania Celli, Ombretta Annibali, Anna Marina Liberati, Manuela Zanni, Chiara Ghiggi, Francesco Pisani, Graziella Pinotti, Fausto Dore, Fabiana Esposito, Maria Cristina Pirosa, Marina Cesaretti, Luisella Bonomini, Umberto Vitolo, Emanuele Zucca
IELSG30 phase 2 trial: intravenous and intrathecal CNS prophylaxis in primary testicular diffuse large B-cell lymphoma. Blood advances 8 (6) (2024)
Annarita Conconi, Annalisa Chiappella, Andrés José Maria Ferreri, Anastasios Stathis, Barbara Botto, Marianna Sassone, Gianluca Gaidano, Monica Balzarotti, Francesco Merli, Alessandra Tucci, Anna Vanazzi, Monica Tani, Riccardo Bruna, Lorella Orsucci, Maria Giuseppina Cabras, Melania Celli, Ombretta Annibali, Anna Marina Liberati, Manuela Zanni, Chiara Ghiggi, Francesco Pisani, Graziella Pinotti, Fausto Dore, Fabiana Esposito, Maria Cristina Pirosa, Marina Cesaretti, Luisella Bonomini, Umberto Vitolo, Emanuele Zucca
IELSG30 phase 2 trial: intravenous and intrathecal CNS prophylaxis in primary testicular diffuse large B-cell lymphoma. Blood advances 8 (6) (2024)
Saveria Mazzara, Laura Travaini, Francesca Botta, Chiara Granata, Giovanna Motta, Federica Melle, Stefano Fiori, Valentina Tabanelli, Anna Vanazzi, Safaa Ramadan, Tommaso Radice, Sara Raimondi, Giuliana Lo Presti, Mahila Esmeralda Ferrari, Barbara Alicja Jereczek-Fossa, Corrado Tarella, Francesco Ceci, Stefano A Pileri, Enrico Derenzini
Gene expression profiling and FDG-PET radiomics uncover radiometabolic signatures associated with outcome in DLBCL. Blood advances 7 (4) (2023)
Saveria Mazzara, Laura Travaini, Francesca Botta, Chiara Granata, Giovanna Motta, Federica Melle, Stefano Fiori, Valentina Tabanelli, Anna Vanazzi, Safaa Ramadan, Tommaso Radice, Sara Raimondi, Giuliana Lo Presti, Mahila Esmeralda Ferrari, Barbara Alicja Jereczek-Fossa, Corrado Tarella, Francesco Ceci, Stefano A Pileri, Enrico Derenzini
Gene expression profiling and FDG-PET radiomics uncover radiometabolic signatures associated with outcome in DLBCL. Blood advances 7 (4) (2023)
Saveria Mazzara, Laura Travaini, Francesca Botta, Chiara Granata, Giovanna Motta, Federica Melle, Stefano Fiori, Valentina Tabanelli, Anna Vanazzi, Safaa Ramadan, Tommaso Radice, Sara Raimondi, Giuliana Lo Presti, Mahila Esmeralda Ferrari, Barbara Alicja Jereczek-Fossa, Corrado Tarella, Francesco Ceci, Stefano A Pileri, Enrico Derenzini
Gene expression profiling and FDG-PET radiomics uncover radiometabolic signatures associated with outcome in DLBCL. Blood advances 7 (4) (2023)
Valentina Tabanelli, Federica Melle, Giovanna Motta, Saveria Mazzara, Marco Fabbri, Claudio Agostinelli, Angelica Calleri, Marcello Del Corvo, Stefano Fiori, Daniele Lorenzini, Alessandra Cesano, Annalisa Chiappella, Umberto Vitolo, Enrico Derenzini, Gabriel K Griffin, Scott J Rodig, Anna Vanazzi, Elena Sabattini, Corrado Tarella, Maria Rosaria Sapienza, Stefano A Pileri
The identification of TCF1+ progenitor exhausted T cells in THRLBCL may predict a better response to PD-1/PD-L1 blockade. Blood advances 6 (15) (2022)

Anna Vanazzi.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Anna Vanazzi